05/22/2025
2:17 PM | Molecular Templates (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
04/24/2025
4:00 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
4:27 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
2:53 PM | Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/02/2025
3:13 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
3:11 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
5:04 AM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
3:31 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
8:49 PM | BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
11/18/2024
8:12 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:05 AM | Molecular Templates (Filer)
| Form NT 10-Q | |
Get the Latest News and Ratings for MTEM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter. |
11/12/2024
8:31 AM | Adage Capital Management, L.P. (Filed by)
Molecular Templates (Subject)
| Form SC 13G/A | |
10/28/2024
4:20 PM | Molecular Templates (Filer)
| Form DEF 14A | |
10/17/2024
4:05 PM | Molecular Templates (Filer)
| Form PRE 14A | |
10/11/2024
3:39 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
3:02 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
4:35 PM | Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:36 PM | HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:36 PM | Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:37 PM | Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:41 PM | LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:01 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:36 PM | Molecular Templates (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
3:26 PM | Molecular Templates (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:43 PM | Molecular Templates (Filer)
| Form DEF 14A | |
08/13/2024
3:44 PM | Molecular Templates (Filer)
| Form DEFA14A | |
08/13/2024
3:47 PM | Molecular Templates (Filer)
| Form ARS | |
